Digital repository of Slovenian research organisations

Show document
A+ | A- | Help | SLO | ENG

Title:Vloga interferona pri zdravljenju kožnih limfomov
Authors:ID Dolenc-Voljč, Mateja (Author)
Files:.pdf PDF - Presentation file, download (115,16 KB)
MD5: FE1957BA2DD45BF4CD56175179EA19F2
PID: 20.500.12556/dirros/5ce1833c-2087-4605-9227-ea85ac5be850
 
Language:Slovenian
Typology:1.04 - Professional Article
Organization:Logo OI - Institute of Oncology
Abstract:Interferon alfa se že mnogo let uspešno uporablja za zdravljenje kožnih T-celičnih limfomov in je za to bolezen še vedno nepogrešljivo zdravilo. Pri kožnih limfomih izkoriščamo predvsem njegovo antiproliferativno in imunomodulatorno delovanje. V sodobnih smernicah za zdravljenje kožnih T-celičnih limfomov je zdravilo izbire v stadijih IIB in III, kjer se pogosto uporablja v kombinaciji s sistemsko PUVA ali s sistemskim retinoidom. V monoterapiji se priporoča v stadijih IA do IIA, kadar so izčrpane lokalne možnosti zdravljenja. Kot vzdrževalno zdravljenje v manjših odmerkih pomembno podaljša remisijo. Režim zdravljenja prilagajamo individualno, glede na stadij bolezni, razširjenost kožnih sprememb in bolnikovo odzivnost na zdravilo. Zdravljenje je povezano z nekaterimi akutnimi in kroničnimi neželenimi sopojavi, ki so pogostejši pri večjih odmerkih, vendar so predvidljivi in praviloma reverzibilni.
Publication status:Published
Publication version:Version of Record
Year of publishing:2010
Number of pages:str. 17-18
Numbering:Letn. 14, št. 1
PID:20.500.12556/DiRROS-8586 New window
UDC:616.5
ISSN on article:1408-1741
URN:URN:NBN:SI:doc-5ALSEI5X
COBISS.SI-ID:28131545 New window
Copyright:by Authors
Note:BSDOCID156461;
Publication date in DiRROS:31.08.2018
Views:3974
Downloads:960
Metadata:XML DC-XML DC-RDF
:
Copy citation
  
Share:Bookmark and Share


Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:Onkologija
Shortened title:Onkologija
Publisher:Onkološki inštitut
ISSN:1408-1741
COBISS.SI-ID:65324032 New window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Licensing start date:31.08.2018

Secondary language

Language:English
Title:The Role of Interferon in the Treatment of Cutaneous T-Cell Lymphoma
Abstract:IFN-alpha has been used successfully for the treatment of cutaneous T-cell lymphoma for many years and it remains an indispensable drug for this condition. Its antiproliferative and immunomodulatory properties are used in the treatment of this disease. According to the current guidelines for the treatment of cutaneous T-cell lymphoma, it is considered as the first-line drug for stages IIB and III, where it is often administered concomitantly with systemic PUVA and retinoids. As monotherapy, it is recommended in stages IA and IIA, if skin directed therapies are not effective. As a maintenance therapy with low dosages, it is associated with prolongation of the duration of remissions. Optimal treatment regimen is adjusted individually, according to the stage of disease, dissemination of skin lesions and the patient’s tolerance for IFN. Several acute and chronic side effects can occur during the treatment with IFN-alpha, which are dose-related, predictable and often reversible.


Archive

niGradiv

Back